Nivolumab (NIVO) plus platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial.

被引:7
作者
Forde, Patrick M. [1 ]
Spicer, Jonathan [2 ]
Lu, Shun [3 ]
Provencio, Mariano [4 ]
Mitsudomi, Tetsuya [5 ]
Awad, Mark M. [6 ]
Felip, Enriqueta [7 ]
Broderick, Stephen [1 ]
Brahmer, Julie [1 ]
Swanson, Scott J. [6 ]
Kerr, Keith [8 ]
Wang, Changli [9 ]
Saylors, Gene B. [10 ]
Tanaka, Fumihiro [11 ]
Ito, Hiroyuki [12 ]
Chen, Ke-Neng [13 ]
Dorange, Cecile [14 ]
Cai, Junliang [14 ]
Fiore, Joseph [14 ]
Girard, Nicholas [15 ]
机构
[1] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[3] Shanghai Chest Hosp, Shanghai, Peoples R China
[4] Hosp Univ Puerta de Hierro, Madrid, Spain
[5] Kindai Univ, Fac Med, Osaka, Japan
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Vall dHebron Inst Oncol, Barcelona, Spain
[8] Aberdeen Royal Infirm, Aberdeen, Scotland
[9] Tianjin Med Univ Canc Inst & Hosp, Tianjin Lung Canc Ctr, Tianjin, Peoples R China
[10] Charleston Oncol, Charleston, SC USA
[11] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[12] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[13] Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing, Peoples R China
[14] Bristol Myers Squibb, Princeton, NJ USA
[15] Inst Curie, Inst Thorax Curie Montsouris, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT003
引用
收藏
页数:2
相关论文
empty
未找到相关数据